Obtaining U.S. Food and Drug Administration approval for a drug, even after multiple trials in various phases, is not the easiest thing for a pharma company to do. BioMarin(NASDAQ:BMRN) knows this as well as any company that has been rejected for approval…
Why is the crypto market going up today? (March 2)
March 3, 2026
